StockData
Xeris Biopharma Holdings, Inc. logo

Xeris Biopharma Holdings, Inc. (XERS) stock

XERSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 10/30
$16.99+0.19 (+1.13%)

Close on Nov 18, 2026Market cap $3.10BP/E –Yield –

Xeris Biopharma market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Xeris Biopharma's market cap was $2.87B on Nov 11, 2026, against $1.19B a year earlier. Over the last 5 years it ranged from $138.39M to $2.87B, with a median of $367.60M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$2.87B+120.7%
2025Dec 31, 2025$1.30B+157.2%
2024Dec 31, 2024$505.12M+55.7%
2023Dec 29, 2023$324.46M+79.4%
2022Dec 30, 2022$180.83M-7.2%
2021Dec 31, 2021$194.84M–

More Xeris Biopharma figures

See a number that looks wrong?